Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia-Pacific region

被引:27
作者
Handoko, HY
Nancarrow, DJ
Hayward, NK
Ohaeri, JU
Aghanwa, H
McGrath, JJ
Levinson, DF
Johns, C
Walters, MK
Nertney, DA
Srinivasan, TN
Thara, R
Mowry, BJ
机构
[1] Queensland Ctr Schizophrenia Res, Ctr Mental Hlth, Wacol, Qld 4076, Australia
[2] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
[3] St Giles Hosp, Suva, Fiji
[4] Fiji Sch Med, Suva, Fiji
[5] Univ Queensland, Dept Psychiat, Brisbane, Qld, Australia
[6] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
[7] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia
[8] Schizophrenia Res Fdn India, Madras, Tamil Nadu, India
关键词
tumor necrosis factor; schizophrenia; polymorphism; promoter; Fiji; India; Australia; HLA;
D O I
10.1002/ajmg.b.20059
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A single nucleotide polymorphism (TNF-308A) within the promoter region of the gene encoding tumor necrosis factor (TNF), has been significantly associated with schizophrenia in a study of Italian patients and control subjects Boin et al. [2001: Mol Psychiatry 6:79-82]. We have applied case-control analyses to examine TNF promoter haplotypes (containing TNF-308 and two additional promoter variants: TNF-376 and TNF-238) in four schizophrenia cohorts drawn from Australian, Indian Fijian, Indigenous Fijian, and Brahmin populations. In addition, we have applied the sibling transmission disequilibrium (STD) test to promoter haplotypes within 81 trios drawn from Australian Caucasian pedigrees with multiple schizophrenia cases, and 86 trios drawn from the Brahmin population of Tamil Nadu province in Southern India. Within each of these cohorts, we found no evidence of recombination between these tightly linked promoter variants, supporting previous studies which demonstrated that only a subset of the eight possible haplotypes exist. Of the four observed haplotypes, we and others have observed only one carries the TNF-308A variant allele. We report no significant differences in TNF promoter haplotype frequencies between the patient and control groups within each population, although the Indian Fijian cohort showed a trend towards reduced TNF-308A alleles amongst schizophrenia cases (P = 0.07). We found no evidence of bias in TNF promoter haplotype transmission to schizophrenia probands. Very similar results were obtained when only the TNF-308 polymorphism was considered. Taken together, these data provide no support for the involvement of TNF promoter variants TNF-308, TNF-376, and TNF-238 in schizophrenia susceptibility within four ethnically distinct cohorts. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 38 条
[1]   Functional analysis of linker-scan mutants spanning the-376-308,-244, and-238 polymorphic sites of the TNF-α promoter [J].
Bayley, JP ;
de Rooij, H ;
van den Elsen, PJ ;
Huizinga, TWJ ;
Verweij, CL .
CYTOKINE, 2001, 14 (06) :316-323
[2]   Association between-G308A tumor necrosis factor alpha gene polymorphism and schizophrenia [J].
Boin, F ;
Zanardini, R ;
Pioli, R ;
Altamura, CA ;
Maes, M ;
Gennarelli, M .
MOLECULAR PSYCHIATRY, 2001, 6 (01) :79-82
[3]  
Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516
[4]   Maternal cytokine levels during pregnancy and adult psychosis [J].
Buka, SL ;
Tsuang, MT ;
Torrey, EF ;
Klebanoff, MA ;
Wagner, RL ;
Yolken, RH .
BRAIN BEHAVIOR AND IMMUNITY, 2001, 15 (04) :411-420
[5]   THE MAJOR HISTOCOMPATIBILITY COMPLEX REGION MARKED BY HSP70-1 AND HSP70-2 VARIANTS IS ASSOCIATED WITH CLOZAPINE-INDUCED AGRANULOCYTOSIS IN 2 DIFFERENT ETHNIC-GROUPS [J].
CORZO, D ;
YUNIS, JJ ;
SALAZAR, M ;
LIEBERMAN, JA ;
HOWARD, A ;
AWDEH, Z ;
ALPER, CA ;
YUNIS, EJ .
BLOOD, 1995, 86 (10) :3835-3840
[6]   Combining the sibling disequilibrium test and transmission disequilibrium test for Multiallelic markers [J].
Curtis, D ;
Miller, MB ;
Sham, PC .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) :1785-1786
[7]  
DALFONSO S, 1994, IMMUNOGENETICS, V39, P150
[8]   Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment [J].
Erbagci, AB ;
Herken, H ;
Köylüoglu, O ;
Yilmaz, N ;
Tarakçioglu, M .
MEDIATORS OF INFLAMMATION, 2001, 10 (03) :109-115
[9]   Recipient HLA-DR3, tumour necrosis factor-α promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts [J].
Evans, PC ;
Smith, S ;
Hirschfield, G ;
Rigopoulou, E ;
Wreghitt, TG ;
Wight, DGD ;
Taylor, CJ ;
Alexander, GJM .
JOURNAL OF HEPATOLOGY, 2001, 34 (05) :711-715
[10]   Polymorphisms in the TNF gene cluster and MHC serotypes in the West of Scotland [J].
Gallagher, G ;
Eskdale, J ;
Oh, HH ;
Richards, SD ;
Campbell, DA ;
Field, M .
IMMUNOGENETICS, 1997, 45 (03) :188-194